Hindustantimes wants to start sending you push notifications. Click allow to subscribe

Sinopharm chairman says can provide over billion Covid-19 vaccine doses to world in second half of 2021

That level of supply capability assumes vaccination demand in China is being met, China National Pharmaceutical Group's chairman Liu Jingzhen said.
Two vaccines from Sinopharm are being used in China, one of which has gained emergency use approval from the World Health Organization, a prerequisite for a vaccine to be included in the COVAX initiative.(AFP)
Published on Jun 02, 2021 09:29 PM IST
Reuters | , Beijing

China National Pharmaceutical Group (Sinopharm) has the capacity to provide more than 1 billion Covid-19 vaccine doses to the world beyond China in the second half of this year, the firm's chairman Liu Jingzhen said late on Wednesday.

That level of supply capability assumes vaccination demand in China is being met, Liu said at a panel of the Global Health Forum of the Boao Forum for Asia.

"Our annual production capacity exceeds 5 billion doses," Liu said, "This is our own capacity."

He declined to disclose how many shots the state-backed drugmaker has agreed to give to the global COVAX programme for sharing doses, mainly with poor countries.

Two vaccines from Sinopharm are being used in China, one of which has gained emergency use approval from the World Health Organization, a prerequisite for a vaccine to be included in the COVAX initiative.

Liu said Sinopharm has also planned a manufacturing facility for a third shot, which is being tested in an early-stage clinical trial.

RELATED STORIES

The GAVI vaccine alliance is in talks with Sinovac Biotech , another major Covid-19 vaccine provider from China, to expand the COVAX portfolio, a GAVI spokesperson said on Wednesday.

China promised in February to provide 10 million doses to COVAX.

SHARE THIS ARTICLE ON
This site uses cookies

This site and its partners use technology such as cookies to personalize content and ads and analyse traffic. By using this site you agree to its privacy policy. You can change your mind and revisit your choices at anytime in future.

OPEN APP